Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Initial immunotherapy patient characteristics
| Number | Percentage (%) | |
|---|---|---|
| Initial immunotherapy regimen | ||
| paclitaxel/nab-paclitaxel ± platinum + ICI | 7 | 50.0 |
| pemetrexed ± platinum + ICI | 6 | 42.9 |
| pemetrexed ± platinum + bevacizumab + ICI | 1 | 7.1 |
| Immune maintenance | ||
| Yes | 6 | 42.9 |
| No | 8 | 57.1 |
| Rechallenge with the same ICI | ||
| Yes | 8 | 57.1 |
| No | 6 | 42.9 |
| Best overall response to initial ICI therapy | ||
| CR/PR | 7 | 50.0 |
| SD/PD | 7 | 50.0 |
| Initial ICI therapy PFS | ||
| > 6 months | 10 | 71.4 |
| ≤ 6 months | 4 | 28.6 |
